Determinants of plasma calretinin in patients with malignant pleural mesothelioma
暂无分享,去创建一个
T. Brüning | Jan Gleichenhagen | G. Johnen | B. Pesch | H. Rihs | D. Taeger | T. Wiethege | S. Casjens | A. Brik | J. Kollmeier | Katharina Wichert | D. Weber | I. Raiko | O. Hagemeyer | M. Lehnert | P. Rozynek | S. Stephan-Falkenau | Katarzyna Burek | Sandra Zilch-Schöneweis | C. Töpfer | Alexander Katarzyna Bettina Swaantje Jan Olaf Heike Monika C Brik Burek Dumont Casjens Gleichenhagen | B. Dumont | H. Heimann | Monika Kobek | Claudia Lechtenfeld | S. Meier | S. Naumann | C. Nöllenheidt | Simone Putzke | Sandra Schonefeld | K. Szafranski
[1] P. Wimberger,et al. Serum calretinin as an independent predictor for platinum resistance and prognosis in ovarian cancer , 2019, Geburtshilfe und Frauenheilkunde.
[2] T. Brüning,et al. Mesothelin, Calretinin, and Megakaryocyte Potentiating Factor as Biomarkers of Malignant Pleural Mesothelioma , 2019, Lung.
[3] Jonathan L. Robinson,et al. A Systematic Investigation of the Malignant Functions and Diagnostic Potential of the Cancer Secretome , 2019, Cell reports.
[4] B. Schwaller,et al. Calretinin promotes invasiveness and EMT in malignant mesothelioma cells involving the activation of the FAK signaling pathway , 2018, Oncotarget.
[5] T. Brüning,et al. Prediagnostic detection of mesothelioma by circulating calretinin and mesothelin – a case-control comparison nested into a prospective cohort of asbestos-exposed workers , 2018, Scientific Reports.
[6] N. Maskell,et al. Current treatments and trials in malignant pleural mesothelioma , 2018, The clinical respiratory journal.
[7] T. Brüning,et al. Biomarkers for Predicting Malignant Pleural Mesothelioma in a Mexican Population , 2018, International journal of medical sciences.
[8] J. Creaney,et al. Malignant Mesothelioma Biomarkers: From Discovery to Use in Clinical Practice for Diagnosis, Monitoring, Screening, and Treatment , 2017, Chest.
[9] T. Brüning,et al. Calretinin as a blood-based biomarker for mesothelioma , 2017, BMC Cancer.
[10] T. Brüning,et al. Incidence of malignant mesothelioma in Germany 2009–2013 , 2017, Cancer Causes & Control.
[11] Fuqiang Wen,et al. Diagnostic Accuracy of Calretinin for Malignant Mesothelioma in Serous Effusions: a Meta-analysis , 2015, Scientific Reports.
[12] B. Schwaller,et al. Calretinin is essential for mesothelioma cell growth/survival in vitro: A potential new target for malignant mesothelioma therapy? , 2013, International journal of cancer.
[13] T. Gerds,et al. Low ERCC1 Expression in Malignant Pleural Mesotheliomas Treated with Cisplatin and Vinorelbine Predicts Prolonged Progression-Free Survival , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[14] J. Creaney,et al. Serum Soluble Mesothelin Concentrations in Malignant Pleural Mesothelioma: Relationship to Tumor Volume, Clinical Stage and Changes in Tumor Burden , 2010, Clinical Cancer Research.
[15] C. Comin,et al. h-Caldesmon, Calretinin, Estrogen Receptor, and Ber-EP4: A Useful Combination of Immunohistochemical Markers for Differentiating Epithelioid Peritoneal Mesothelioma From Serous Papillary Carcinoma of the Ovary , 2007, The American journal of surgical pathology.
[16] Alan T. Remaley,et al. Detection and Quantitation of Serum Mesothelin, a Tumor Marker for Patients with Mesothelioma and Ovarian Cancer , 2006, Clinical Cancer Research.
[17] Joan G. Jones,et al. Expression of Calretinin in Human Ovary, Testis, and Ovarian Sex Cord-Stromal Tumors , 2001, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[18] G. Viale,et al. Calretinin: a novel immunocytochemical marker for mesothelioma. , 1996, The American journal of surgical pathology.
[19] Robert Koch-Institut,et al. Krebs in Deutschland 2015/2016 , 2019 .
[20] A. Gown,et al. Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group. , 2018, Archives of pathology & laboratory medicine.
[21] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[22] T. Brüning,et al. Open Access Technical Advance Development of an Enzyme-linked Immunosorbent Assay for the Detection of Human Calretinin in Plasma and Serum of Mesothelioma Patients , 2022 .